日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model

在小鼠 COVID-19 模型中发现具有协同抗病毒功效的 SARS-CoV-2 PLpro 抑制剂和 RIPK1 抑制剂

Shan, Hengyue; Zhou, Yuzheng; Qin, Ying; Guo, Taijie; Zhang, Xiao; Xiang, Huaijiang; He, Qinyang; Shi, Chen; Li, Dekang; Liu, Jingli; Qi, Chunting; Chen, Shi; Dong, Jiajia; Xu, Gang; Li, Ying; Zhang, Zheng; Tan, Li

Methylation-Induced Permanent Charge Polarization in Covalent Organic Frameworks for Visible Light-Driven Water Decontamination and Disinfection

甲基化诱导共价有机框架永久电荷极化用于可见光驱动的水净化和消毒

Peng, Xuewen; Pang, Huaji; Feng, Niu; Huang, Dekang; Jiao, Chunpeng; Zeng, Jingbin; Xiang, Yonggang; Chen, Yiping

Corrigendum to 'A dual-functional in situ hydrogel for delivering vitamin E-based lipid nanoparticles to enhance cancer immunotherapy' [Mater. Today Bio, Volume 35, December 2025, 102289]

对“一种用于递送维生素 E 基脂质纳米颗粒以增强癌症免疫疗法的双功能原位水凝胶”的更正[Mater. Today Bio,第 35 卷,2025 年 12 月,102289]

Zheng, Chaozhu; Nie, Dekang; Wang, Zhao; Li, Nanjun; Jin, Xiaolu; Zhou, Ya; Wang, Jun; Xu, Jun; Cai, Zhengqing; Xu, Binbin; Wei, Zizhuo; Zhou, Feng; Qi, Yiming

Targeting the ANXA2-CD63-exosomal PD-L1 axis in hepatocellular carcinoma: A novel mechanism of immune evasion and its implications for precision immunotherapy.

靶向肝细胞癌中的 ANXA2-CD63-外泌体 PD-L1 轴:一种新的免疫逃逸机制及其对精准免疫治疗的意义。

Zhang Jian, Gu Ying, Zhao Fangchao, Chen Yong, Xia Yuqing, Gao Dekang, Yuan Qiang, Bai Xuming

Anatid herpesvirus 1 UL51 protein is palmitoylated by DHHC9 and DHHC18 for viral replication and virulence.

鸭疱疹病毒 1 UL51 蛋白通过 DHHC9 和 DHHC18 进行棕榈酰化,以促进病毒复制和毒力。

Liu Xiaolan, Zhang Ruihao, Wang Mingshu, Cheng Anchun, Zhang Wei, Yang Qiao, Ou Xumin, Sun Di, He Yu, Tian Bin, Wu Zhen, Zhang Shaqiu, Huang Juan, Wu Ying, Yu Yanling, Zhang Ling, Zhao XinXin, Zhu Dekang, Chen Shun, Jia Renyong, Liu Mafeng

NS2B is indispensable for NS3/NS5 interaction of Tembusu virus in living cells

在活细胞中,NS2B对于坦布苏病毒的NS3/NS5相互作用至关重要。

He, Yu; Shi, Yanfan; Wu, Zhen; Wang, Tao; Wang, Mingshu; Jia, Renyong; Zhu, Dekang; Liu, Mafeng; Zhao, Xinxin; Yang, Qiao; Wu, Ying; Zhang, Shaqiu; Huang, Juan; Ou, Xumin; Sun, Di; Tian, Bin; Cheng, Anchun; Chen, Shun

Brefeldin A inhibits duck plague virus replication by impairing virion envelopment

布雷菲德菌素A通过损害病毒颗粒包膜来抑制鸭瘟病毒的复制。

Wang, Xuetong; Tian, Bin; Liu, Zaihui; Cai, Dongjie; Tian, Yanming; Wang, Mingshu; Wu, Ying; Yang, Qiao; Zhang, Shaqiu; Zhu, Dekang; Liu, Mafeng; Zhao, Xinxin; Sun, Di; Huang, Juan; Ou, Xumin; Wu, Zhen; He, Yu; Jia, Renyong; Chen, Shun; Cheng, Anchun

A targeted mutation in ICP8 attenuates duck plague virus by disrupting replication and proposes a vaccine strategy.

ICP8 中的靶向突变通过破坏复制来减弱鸭瘟病毒,并提出了一种疫苗策略。

Wu Ying, Sun Anyang, Zhan Haichuan, Liang Zhiyuan, Yang Qiqi, Wang Mingshu, Liu Mafeng, Chen Shun, Jia Renyong, Yang Qiao, Tian Bin, Ou Xumin, Wu Zhen, Huang Juan, Sun Di, Zhu Dekang, Zhao Xin-Xin, Zhang Shaqiu, He Yu, Cheng Anchun

ERAD inhibitor Eeyarestatin I (EerI) suppresses duck plague virus by restoring STING-mediated antiviral immunity.

ERAD 抑制剂 Eeyarestatin I (EerI) 通过恢复 STING 介导的抗病毒免疫力来抑制鸭瘟病毒。

Tian Yanming, Tian Bin, Liu Zaihui, Cai Dongjie, Xiao Zhen, Wang Mingshu, Wu Ying, Yang Qiao, Zhang Shaqiu, Zhu Dekang, Liu Mafeng, Zhao Xinxin, Sun Di, Huang Juan, Ou Xumin, Wu Zhen, He Yu, Pan Yuhong, Jia Renyong, Chen Shun, Cheng Anchun

Targeting the pan-viral host protein HSPA8 with oxymatrine as a novel therapy against duck hepatitis a virus infection.

以苦参碱为靶点,靶向泛病毒宿主蛋白 HSPA8,作为治疗鸭肝炎甲型病毒感染的新疗法。

Sun Di, Cheng Wenze, Li Zheng, Yao Hui, Liu Mafeng, Wang Mingshu, Chen Shun, Zhu Yukun, Wang Jingming, Deng Yuan, Xu Funeng, Ou Xumin, Jia Renyong, Zhu Dekang, Zhao Xinxin, Yang Qiao, Wu Ying, Zhang Shaqiu, Huang Juan, Tian Bin, He Yu, Wu Zhen, Cheng Anchun